Edison International Free cash flow increased by 64.9% to -$112.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 39.1%, from -$184.00M to -$112.00M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows an upward trend with a -39.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.68B | -$397.00M | -$1.13B | -$415.00M | -$1.06B | -$624.00M | -$468.00M | -$1.41B | -$585.00M | $554.00M | -$602.00M | -$236.00M | -$1.09B | $961.00M | -$326.00M | -$184.00M | -$830.00M | $618.00M | -$319.00M | -$112.00M |
| QoQ Change | — | +85.2% | -184.6% | +63.3% | -154.2% | +40.9% | +25.0% | -202.1% | +58.6% | +194.7% | -208.7% | +60.8% | -362.7% | +188.0% | -133.9% | +43.6% | -351.1% | +174.5% | -151.6% | +64.9% |
| YoY Change | — | — | — | — | +60.6% | -57.2% | +58.6% | -240.7% | +44.5% | +188.8% | -28.6% | +83.3% | -86.7% | +73.5% | +45.8% | +22.0% | +24.0% | -35.7% | +2.1% | +39.1% |